These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33679480)

  • 21. Digital Approaches to Remote Pediatric Health Care Delivery During the COVID-19 Pandemic: Existing Evidence and a Call for Further Research.
    Badawy SM; Radovic A
    JMIR Pediatr Parent; 2020 Jun; 3(1):e20049. PubMed ID: 32540841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential Case Management Practices Amidst the Novel Coronavirus Disease 2019 (COVID-19) Crisis: Part 1: Tele-Case Management, Surge Capacity, Discharge Planning, and Transitions of Care.
    Tahan HM
    Prof Case Manag; 2020; 25(5):248-266. PubMed ID: 32452941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.
    Wilkinson R; Hines L; Holland A; Mandal S; Phipps E
    Harm Reduct J; 2020 Dec; 17(1):95. PubMed ID: 33261636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol.
    Auriacombe M; Roux P; Briand Madrid L; Kirchherr S; Kervran C; Chauvin C; Gutowski M; Denis C; Carrieri MP; Lalanne L; Jauffret-Roustide M;
    BMJ Open; 2019 Feb; 9(2):e023683. PubMed ID: 30796121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harm reduction approaches to alcohol use: health promotion, prevention, and treatment.
    Marlatt GA; Witkiewitz K
    Addict Behav; 2002; 27(6):867-86. PubMed ID: 12369473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
    Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
    Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
    Ekhtiari H; Noroozi A; Farhoudian A; Radfar SR; Hajebi A; Sefatian S; Zare-Bidoky M; Razaghi EM; Mokri A; Rahimi-Movaghar A; Rawson R
    Addiction; 2020 Jul; 115(7):1395-1403. PubMed ID: 31737965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "If I knew I could get that every hour instead of alcohol, I would take the cannabis": need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs.
    Pauly B; Brown M; Chow C; Wettlaufer A; ; Graham B; Urbanoski K; Callaghan R; Rose C; Jordan M; Stockwell T; Thomas G; Sutherland C
    Harm Reduct J; 2021 Jun; 18(1):65. PubMed ID: 34162375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report.
    Crowley D; Delargy I
    Harm Reduct J; 2020 Jul; 17(1):49. PubMed ID: 32680520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction.
    ; Austin T; Boyd J
    Harm Reduct J; 2021 Jan; 18(1):1. PubMed ID: 33407500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harm reduction: roads less travelled to the holy grail.
    Roche AM; Evans KR; Stanton WR
    Addiction; 1997 Sep; 92(9):1207-12. PubMed ID: 9374022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of a participatory needs assessment demonstrate an opportunity to involve people who use alcohol in drug user activism and harm reduction.
    Crabtree A; Latham N; Bird L; Buxton J
    Harm Reduct J; 2016 Dec; 13(1):37. PubMed ID: 27938376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes toward harm reduction and abstinence-only approaches to alcohol misuse among Alaskan college students.
    Skewes MC; Gonzalez VM
    Int J Circumpolar Health; 2013; 72():. PubMed ID: 23984274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A feasibility trial of an intervention in alcohol dependence for structured preparation before detoxification versus usual care: the SPADe trial results.
    Kouimtsidis C; Houghton B; Gage H; Notley C; Maskrey V; Clark A; Holland R; Lingford-Hughes A; Punukollu B; Touray M; Duka T
    Pilot Feasibility Stud; 2021 Jul; 7(1):148. PubMed ID: 34325743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-harm and the COVID-19 pandemic: A study of factors contributing to self-harm during lockdown restrictions.
    Hawton K; Lascelles K; Brand F; Casey D; Bale L; Ness J; Kelly S; Waters K
    J Psychiatr Res; 2021 May; 137():437-443. PubMed ID: 33774538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic.
    Bikson M; Hanlon CA; Woods AJ; Gillick BT; Charvet L; Lamm C; Madeo G; Holczer A; Almeida J; Antal A; Ay MR; Baeken C; Blumberger DM; Campanella S; Camprodon JA; Christiansen L; Loo C; Crinion JT; Fitzgerald P; Gallimberti L; Ghobadi-Azbari P; Ghodratitoostani I; Grabner RH; Hartwigsen G; Hirata A; Kirton A; Knotkova H; Krupitsky E; Marangolo P; Nakamura-Palacios EM; Potok W; Praharaj SK; Ruff CC; Schlaug G; Siebner HR; Stagg CJ; Thielscher A; Wenderoth N; Yuan TF; Zhang X; Ekhtiari H
    Brain Stimul; 2020; 13(4):1124-1149. PubMed ID: 32413554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the COVID-19 lockdown on drug service provision in European prisons.
    Montanari L; Teltzrow R; Van Malderen S; Ranieri R; Martín Peláez JA; Vandam L; Mounteney J; Pirona A; Meroueh F; Giraudon I; Matias J; Skarupova K; Royuela L; Morel d'Arleux J
    Int J Prison Health; 2021 Oct; 17(3):217-232. PubMed ID: 34410050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.
    Boucher LM; Marshall Z; Martin A; Larose-Hébert K; Flynn JV; Lalonde C; Pineau D; Bigelow J; Rose T; Chase R; Boyd R; Tyndall M; Kendall C
    Harm Reduct J; 2017 May; 14(1):18. PubMed ID: 28494774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19.
    Seaman A; Leichtling G; Stack E; Gray M; Pope J; Larsen JE; Leahy JM; Gelberg L; Korthuis PT
    AIDS Behav; 2021 May; 25(5):1331-1339. PubMed ID: 33471243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "The post-COVID era": challenges in the treatment of substance use disorder (SUD) after the pandemic.
    López-Pelayo H; Aubin HJ; Drummond C; Dom G; Pascual F; Rehm J; Saitz R; Scafato E; Gual A
    BMC Med; 2020 Jul; 18(1):241. PubMed ID: 32731868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.